Source recordFED

Laurent Pharmaceuticals Inc.

Federal grants & contributions· Industrial Research Assistance Program – Contributions to Firms· National Research Council Canada· FY2020· $665,000· BN 835517442· QC

Description

Formulation scale-up & preclinical proof-of-principle in multiple animal models of rare diseases.

Amendment chain · 4 entries

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $350,000 at start, $665,000 after amendment #3 (+$315,000).

$665,000$0Original · 2019-10-01 (start date) · total $350,000Amendment 1 · 2020-04-28 · total $500,000Amendment 2 · 2020-07-22 · total $665,000Amendment 3 · 2021-02-02 · total $665,000
  • #02019-10-01$350,000
  • #12020-04-28$500,000+$150,000
  • #22020-07-22$665,000+$165,000
  • #32021-02-02$665,000
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2019-10-01(start date)$350,000—Formulation scale-up & preclinical proof-of-principle in multiple animal models of rare diseases.
#1 amendment2020-04-28$500,000+$150,000Formulation scale-up & preclinical proof-of-principle in multiple animal models of rare diseases.
#2 amendment2020-07-22$665,000+$165,000Formulation scale-up & preclinical proof-of-principle in multiple animal models of rare diseases.
#3 amendment2021-02-02$665,000+$0Formulation scale-up & preclinical proof-of-principle in multiple animal models of rare diseases.

Related records · 10

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (business number 835517442)

RefDepartment · programCurrent valueFY
172-2022-2023-Q4-1002706National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$7,000,000FY2023
172-2020-2021-Q4-967293National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Innovation Assistance Program$21,676FY2021
172-2020-2021-Q3-958708National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$10,000,000FY2021
172-2020-2021-Q3-960877National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Innovation Assistance Program$48,704FY2021
172-2020-2021-Q1-949490National Research Council Canada | Conseil national de recherches Canada · Innovation Assistance Program$40,656FY2021

Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
172-2025-2026-Q2-1034675Mediphage Bioceuticals, Inc.FY2027$63,380FY2027
172-2025-2026-Q3-1037522OBKIO INC.FY2026$50,000FY2026
172-2025-2026-Q3-1037889SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INCFY2026$25,000FY2026
172-2025-2026-Q2-1034040Griffith Foods LimitedFY2026$54,880FY2026
172-2025-2026-Q3-1037273Apollo Machine & Welding Ltd.FY2026$230,000FY2026

Cite as: Glassbox record view · Federal grants & contributions · 172-2019-2020-Q3-939069 · retrieved 2026-11-16.